Risk Factors for Nonalcoholic Fatty Liver Disease in Patients Presenting to Medical Unit of Secondary Healthcare Facility
DOI:
https://doi.org/10.54112/bcsrj.v6i6.2028Keywords:
Nonalcoholic Fatty Liver Disease, Diabetes Mellitus, Hypertension, Obesity, Thyroid DysfunctionAbstract
Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent and drives substantial metabolic and cardiovascular morbidity. Early recognition of context-specific risk factors is crucial, especially in secondary-care settings with high patient throughput.. Objective: To determine the risk factors for nonalcoholic fatty liver disease in patients presenting to the medical unit of a secondary healthcare facility. Methodology: Two hundred thirty patients aged 25 to 70 years diagnosed with NAFLD based on clinical symptoms such as jaundice, dark urine and itchy skin along with ultrasonographic findings were enrolled. Patients with other liver diseases were excluded. Data on demographics and risk factors were obtained. Risk factors assessed in our study were diabetes, hypertension, obesity and thyroid dysfunction. SPSS 27 was utilized for analysis. Results: The mean age of our 230 patients was 48.13±13.31 years with mean BMI 29.18±2.53 kg/m². The study population was mostly male (58.7%). A majority of patients were from lower and middle socioeconomic background (39.1% and 41.3% respectively). Regarding the risk factors diabetes was 56.1% and hypertension 52.2%, followed by obesity 40.9% and thyroid dysfunction 12.6%. Statistical analysis showed that diabetes and hypertension were associated with older age groups. Thyroid dysfunction showed a potential association with female gender and lower socioeconomic status. Conclusion: Diabetes, hypertension, obesity and thyroid dysfunction are the leading risk factors for NAFLD. Associations were found for diabetes and hypertension with increasing age, while thyroid dysfunction showed an association with female gender.
Downloads
References
Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–24. https://doi.org/10.1016/S0140-6736(20)32511-3
Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: definition and subtypes. Clin Mol Hepatol. 2023;29(Suppl):S5–S16. https://doi.org/10.3350/cmh.2022.0424
Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119(9):1787–98. https://doi.org/10.1093/cvr/cvad067
Younossi ZM, Koenig AB. Global epidemiology of NAFLD—meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64(1):73–84. https://doi.org/10.1002/hep.28431
Wong S, Chan W. Epidemiology of NAFLD in Asia. Indian J Gastroenterol. 2020;39(1):1–8. https://doi.org/10.1007/s12664-019-00940-8
Usman M, Yaqoob Y, Anjum MA, Hussain A, Ahmad A, Ayyaz M. Risk factors and frequency of non-alcoholic fatty liver disease amongst non-obese individuals. Pak J Med Health Sci. 2021;15(3):862–5. [No DOI assigned].
Wang B, Wang B, Yang Y, Xu J, Hong M, Xia M, et al. Thyroid function and non-alcoholic fatty liver disease in hyperthyroid patients. BMC Endocr Disord. 2021;21(1):27. https://doi.org/10.1186/s12902-021-00694-w
Marušić M, Paić M, Knobloch M, Liberati Pršo AM. NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol. 2021;2021:6613827. https://doi.org/10.1155/2021/6613827
Yuan M, He J, Hu X, Yao L, Chen P, Wang Z, et al. Hypertension and NAFLD risk: insights from the NHANES 2017–2018 and Mendelian randomization analyses. Chin Med J (Engl). 2024;137(4):457–64. https://doi.org/10.1097/CM9.0000000000003141
Godoy-Matos AF, Silva Júnior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12(1):60. https://doi.org/10.1186/s13098-020-00570-y
Mahmood H, Abbas M, Azeem M, Younus I, Qadir A, Habib M. The risk factors associated with non-alcoholic fatty liver disease. Pak J Med Health Sci. 2023;17(4):458–61. https://doi.org/10.53350/pjmhs2023174458
Wang G, Shen X, Wang Y, Lu H, He H, Wang X. Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals. Front Med (Lausanne). 2023;10:1168499. https://doi.org/10.3389/fmed.2023.1168499
Hussain Z, Rind MA, Nazir M, Saleem M. Assessment of risk factors for non-alcoholic fatty liver disease (NAFLD). Pak J Health Sci. 2023;4(5):187–91. https://doi.org/10.54393/pjhs.v4i05.773
Ali A, Amin MJ, Ahmed MU, Taj A, Aasim M, Tabrez E. Frequency of non-alcoholic fatty liver disease (NAFLD) and its associated risk factors among type-2 people with diabetes. Pak J Med Sci. 2022;38(1):28–33. https://doi.org/10.12669/pjms.38.1.4968
Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2022;31(1):17–27. https://doi.org/10.7570/jomes21085
Zhang J, Sun H, Chen L, Zheng J, Hu X, Wang S, Chen T. Relationship between serum TSH level and obesity and NAFLD in euthyroid subjects. J Huazhong Univ Sci Technolog Med Sci. 2012;32(1):47–52. https://doi.org/10.1007/s11596-012-0992-3
Sanober, Rahimoon AG, Shaikh K, Shaikh MN, Kumar K, Channa R. Hypothyroidism in patients with non-alcoholic fatty liver disease (NAFLD). Ann Pak Inst Med Sci. 2025;21(3):571–6. https://doi.org/10.48036/apims.v21i3.1303
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Shah Zaib Alam Khan, Arif Mumtaz

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

